Idexx Laboratories Work in process increased by 4.8% to $34.14M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.5%, from $35.00M to $34.14M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 9.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $25.10M | $24.62M | $26.40M | $27.30M | $30.74M | $30.73M | $28.04M | $31.79M | $29.53M | $29.34M | $28.99M | $28.23M | $32.04M | $32.39M | $31.91M | $35.00M | $35.11M | $33.97M | $32.59M | $34.14M |
| QoQ Change | — | -1.9% | +7.2% | +3.4% | +12.6% | -0.0% | -8.8% | +13.4% | -7.1% | -0.6% | -1.2% | -2.6% | +13.5% | +1.1% | -1.5% | +9.7% | +0.3% | -3.2% | -4.1% | +4.8% |
| YoY Change | — | — | — | — | +22.4% | +24.8% | +6.2% | +16.5% | -3.9% | -4.5% | +3.4% | -11.2% | +8.5% | +10.4% | +10.1% | +24.0% | +9.6% | +4.9% | +2.1% | -2.5% |
| % of Inventories | 10.4% | 9.5% | 9.8% | 9.0% | 9.2% | 8.7% | 7.6% | 8.1% | 7.5% | 7.4% | 7.6% | 7.2% | 8.4% | 8.3% | 8.4% | 8.8% | 8.9% | 8.7% | 8.6% | 8.9% |
| Share Change | — | -0.9pp | +0.3pp | -0.8pp | +0.2pp | -0.6pp | -1.0pp | +0.5pp | -0.7pp | -0.0pp | +0.2pp | -0.4pp | +1.2pp | -0.1pp | +0.0pp | +0.5pp | +0.1pp | -0.3pp | -0.0pp | +0.3pp |